Mycophénolate : l’ANSM rappelle les conditions de sa prescription et de sa délivrance car son utilisation pendant la grossesse persiste - Point d'Information ANSM (10/02/2020)
Powered by
eZ Publish™ CMS Open Source Web Content Management
. Copyright © 1999-2014
eZ Systems AS
(except where otherwise noted). All rights reserved.